The European Commission adopted Regulation (EU) 2024/996 in April 2024, restricting retinol, retinyl acetate, and retinyl palmitate in leave-on cosmetic products to a combined maximum of 0.3% retinol equivalent on the face and 0.05% on the body, with transition periods running to 2027 for face products and beyond for body products. What it changes for a routine: products sold in the EU above those caps will be reformulated or phased out over the transition window — and global brands tend to reformulate once, not per market, so the change reaches shelves well beyond Europe.
Beautyise covers regulatory news from the official documents; this is information about rules, not dermatological advice.
Why is the EU doing this?
Exposure aggregation, not acute danger. The EU's Scientific Committee on Consumer Safety assessed vitamin A in cosmetics in 2023 and concluded that total vitamin A exposure from cosmetics plus diet — retinol is already plentiful in food and stored by the body — could approach upper intake levels for some consumers. The cap is a margin-of-safety measure under the EU's cosmetics framework; the committee did not find that current cosmetic use alone causes vitamin A toxicity. Retinoids remain legal, widely available, and among the most-studied topicals in dermatology; prescription retinoid drugs are regulated separately and unaffected.
What should a routine-builder actually do?
Three practical readouts. Check percentages without alarm: many popular serums already sit at 0.3–0.5%, and 0.3% remains an effective, well-studied concentration — dermatology literature documents benefits across a range of doses, with lower strengths trading some speed for less irritation. Watch the calendar, not panic headlines: brands have until May 2027 for face products to comply, so nothing vanishes overnight, and reformulated versions will roll in gradually. And know that if you use a higher-strength product today, nothing in the regulation obliges you to change course mid-tube — the rule governs what may be sold in the EU, and skin tolerances differ enough that strength is a per-person question, ideally with a dermatologist.
What's established: the caps, the dates, the scientific committee's reasoning, all in the adopted regulation. What isn't: how each brand will respond — reformulate, split lines by market, or discontinue — which the transition period will reveal shelf by shelf.